Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F E R Simons

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Allergy|July 11, 2007
Evidence-based management of anaphylaxisF E R Simons, A Sheikh
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 26, 2015
Anaphylaxis and cardiovascular disease: therapeutic dilemmasP Lieberman, F E R Simons
Allergy|August 12, 2008
Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy OrganizationS F Kemp, R F Lockey, F E R Simons, et al.
Allergy|June 23, 2015
H1-antihistamines for primary mast cell activation syndromes: a systematic reviewU B Nurmatov, E Rhatigan, F E R Simons, et al.
Allergy|July 11, 2007
H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic reviewA Sheikh, V Ten Broek, S G A Brown, et al.
Allergy|January 31, 2009
Adrenaline for the treatment of anaphylaxis: cochrane systematic reviewA Sheikh, Y A Shehata, S G A Brown, et al.
The Cochrane Database of Systematic Reviews|January 27, 2007
H1-antihistamines for the treatment of anaphylaxis with and without shockA Sheikh, V m ten Broek, S G A Brown, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 17, 2004
Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogsS N Mink, F E R Simons, K J Simons, et al.
Allergy|March 4, 2006
A new recombinant mosquito salivary allergen, rAed a 2: allergenicity, clinical relevance, and cross-reactivityZ Peng, W Xu, H Lam, et al.
Allergy|December 14, 2011
Sublingual allergen immunotherapy: mode of action and its relationship with the safety profileM A Calderón, F E R Simons, H-J Malling, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Allergy|July 11, 2007
Evidence-based management of anaphylaxisF E R Simons, A Sheikh
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|February 26, 2015
Anaphylaxis and cardiovascular disease: therapeutic dilemmasP Lieberman, F E R Simons
Allergy|August 12, 2008
Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy OrganizationS F Kemp, R F Lockey, F E R Simons, et al.
Allergy|June 23, 2015
H1-antihistamines for primary mast cell activation syndromes: a systematic reviewU B Nurmatov, E Rhatigan, F E R Simons, et al.
Allergy|July 11, 2007
H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic reviewA Sheikh, V Ten Broek, S G A Brown, et al.
Allergy|January 31, 2009
Adrenaline for the treatment of anaphylaxis: cochrane systematic reviewA Sheikh, Y A Shehata, S G A Brown, et al.
The Cochrane Database of Systematic Reviews|January 27, 2007
H1-antihistamines for the treatment of anaphylaxis with and without shockA Sheikh, V m ten Broek, S G A Brown, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 17, 2004
Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogsS N Mink, F E R Simons, K J Simons, et al.
Allergy|March 4, 2006
A new recombinant mosquito salivary allergen, rAed a 2: allergenicity, clinical relevance, and cross-reactivityZ Peng, W Xu, H Lam, et al.
Allergy|December 14, 2011
Sublingual allergen immunotherapy: mode of action and its relationship with the safety profileM A Calderón, F E R Simons, H-J Malling, et al.
Pageof 4